Skip to main content

Larimar Therapeutics, Inc.

LRMR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001374690

In the last 90 days, Larimar Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 163 institutions reported holding it in 13F filings for Q2 2026, worth $291.4M in total; no superinvestor holds it.

13F holders, Q4 2024

Institutional positions in Larimar Therapeutics, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
116
−5 vs. Q3 2024
Shares held
63.4M
−659.3K (−1.0%) vs. Q3 2024
Total value
$245.5M
−$174.3M (−41.5%) vs. Q3 2024
New holders
22
44 more added
Sold out
27
32 more reduced

2 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting LRMR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2024: 116 institutions
Q1 2021: 57 institutionsQ2 2021: 45 institutionsQ3 2021: 54 institutionsQ4 2021: 49 institutionsQ1 2022: 45 institutionsQ2 2022: 40 institutionsQ3 2022: 59 institutionsQ4 2022: 48 institutionsQ1 2023: 69 institutionsQ2 2023: 65 institutionsQ3 2023: 65 institutionsQ4 2023: 69 institutionsQ1 2024: 104 institutionsQ2 2024: 107 institutionsQ3 2024: 123 institutionsQ4 2024: 116 institutionsQ1 2025: 103 institutionsQ2 2025: 116 institutionsQ3 2025: 136 institutionsQ4 2025: 136 institutionsQ1 2026: 162 institutionsQ2 2026: 163 institutions
Value heldQ4 2024: $245.5M
Q1 2021: $206.1MQ2 2021: $142.8MQ3 2021: $167.5MQ4 2021: $157.2MQ1 2022: $61.8MQ2 2022: $28.2MQ3 2022: $123.9MQ4 2022: $160.1MQ1 2023: $174.2MQ2 2023: $120.2MQ3 2023: $153.0MQ4 2023: $179.6MQ1 2024: $482.8MQ2 2024: $473.5MQ3 2024: $421.3MQ4 2024: $245.5MQ1 2025: $131.9MQ2 2025: $180.1MQ3 2025: $274.8MQ4 2025: $277.0MQ1 2026: $394.8MQ2 2026: $291.4M
Institutions holding LRMR and their total value by quarter
QuarterHoldersValue
Q2 2026163$291.4M
Q1 2026162$394.8M
Q4 2025136$277.0M
Q3 2025136$274.8M
Q2 2025116$180.1M
Q1 2025103$131.9M
Q4 2024116$245.5M
Q3 2024123$421.3M
Q2 2024107$473.5M
Q1 2024104$482.8M
Q4 202369$179.6M
Q3 202365$153.0M
Q2 202365$120.2M
Q1 202369$174.2M
Q4 202248$160.1M
Q3 202259$123.9M
Q2 202240$28.2M
Q1 202245$61.8M
Q4 202149$157.2M
Q3 202154$167.5M
Q2 202145$142.8M
Q1 202157$206.1M

Institutions, Q4 2024

Shares, value and share of portfolio for each institution holding Larimar Therapeutics, Inc.; share changes are against Q3 2024.

Institutions holding LRMR in Q4 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Woodline Partners LP622,682$2.41M0.02%−621,869−50.0%Reduced
Fred Alger Management, LLC737,553$2.85M0.01%−49,035−6.2%Reduced
Mangrove Partners770,233$2.98M0.36%−85,582−10.0%Reduced
State Street Corp842,891$3.26M0.00%−71,427−7.8%Reduced
Geode Capital Management, LLC886,414$3.43M0.00%−14,848−1.6%Reduced
Alyeska Investment Group, L.P.984,077$3.81M0.01%+273,920+38.6%Added
Verition Fund Management LLC1,037,748$4.02M0.02%−124,002−10.7%Reduced
Driehaus Capital Management LLC1,269,856$4.91M0.04%−9,232−0.7%Reduced
Adage Capital Partners GP, L.L.C.2,100,000$8.13M0.01%+399,123+23.5%Added
Vanguard Group Inc2,192,925$8.49M0.00%−104,324−4.5%Reduced
BlackRock, Inc.3,265,905$12.6M0.00%+292,952+9.9%Added
Goldman Sachs Group Inc4,152,228$16.1M0.00%−97,263−2.3%Reduced
Blue Owl Capital Holdings LP4,653,040$18.0M4.26%+486,211+11.7%Added
Ra Capital Management, L.P.6,045,351$23.4M0.31%00.0%Unchanged
Janus Henderson Group PLC6,443,286$24.9M0.01%+876,431+15.7%Added
Deerfield Management Company, L.P. (Series C)21,231,974$82.2M1.56%00.0%Unchanged
Schonfeld Strategic Advisors LLC0$00.00%−242,476−100.0%Sold out
Point72 Asset Management, L.P.0$00.00%−207,100−100.0%Sold out
HRT Financial LP0$00.00%−178,413−100.0%Sold out
Atlas Venture Advisors, Inc.0$00.00%−112,184−100.0%Sold out
Artia Global Partners LP0$00.00%−90,490−100.0%Sold out
Corton Capital Inc.0$00.00%−49,598−100.0%Sold out
Citadel Advisors LLC0$00.00%−38,807−100.0%Sold out
Simplex Trading, LLC0$00.00%−26,262−100.0%Sold out
Connor, Clark & Lunn Investment Management Ltd.0$00.00%−23,521−100.0%Sold out
ExodusPoint Capital Management, LP0$00.00%−21,119−100.0%Sold out
J. Goldman & Co LP0$00.00%−19,705−100.0%Sold out
D. E. Shaw & Co., Inc.0$00.00%−16,122−100.0%Sold out
AQR Capital Management LLC0$00.00%−15,712−100.0%Sold out
Commonwealth Equity Services, LLC0$00.00%−15,348−100.0%Sold out
Quarry LP0$00.00%−12,000−100.0%Sold out
Delta Investment Management, LLC0$00.00%−10,848−100.0%Sold out
Virtu Financial LLC0$00.00%−10,843−100.0%Sold out
Quest Partners LLC0$00.00%−9,183−100.0%Sold out
Golden State Equity Partners0$00.00%−2,000−100.0%Sold out
Aspect Partners, LLC0$00.00%−1,000−100.0%Sold out
Point72 Asia (Singapore) Pte. Ltd.0$00.00%−500−100.0%Sold out
Nisa Investment Advisors, LLC0$00.00%−118−100.0%Sold out
Lindbrook Capital, LLC0$00.00%−60−100.0%Sold out
GAMMA Investing LLC0$00.00%−44−100.0%Sold out
Capital Performance Advisors LLP0$00.00%−18−100.0%Sold out
Federated Hermes, Inc.0$00.00%−3−100.0%Sold out
National Bank of Canada0$00.00%−2−100.0%Sold out
Ghost Tree Capital, LLC––––Not filed
PEAK6 Investments LLC––––Not filed